Privacy Notice
You can find more information on the used cookies and how you can subsequently revoke your consent in our Privacy Policy.
Jülich, 8 October – New cancer treatments such as immunotherapy and targeted therapy are very promising. The treatments can be used to fight not just the primary tumour, but also metastases in other organs – in particular the brain. Positron emission tomography (PET) with radioactively labelled amino acids can provide useful additional information for assessing the chances of a treatment being successful in such cases. This has been shown in a study recently released in the renowned Journal of Nuclear Medicine.
You can find more information on the used cookies and how you can subsequently revoke your consent in our Privacy Policy.